Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions

PURPOSE: A fixed-dose combination (FDC) tablet of melitracen/flupentixol has been widely used for depression. The purpose of this study was to assess the safety profile and the relative bioavailability of two FDC products containing 10 mg melitracen and 0.5 mg flupentixol from two different manufact...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lihua, Xu, Chang, Wu, Guolan, Zhou, Huili, Lv, Duo, Zhai, You, Huang, Yujie, Tang, Wenling, Li, Fangqiong, Shentu, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756841/
https://www.ncbi.nlm.nih.gov/pubmed/31571834
http://dx.doi.org/10.2147/DDDT.S207561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756841/
https://www.ncbi.nlm.nih.gov/pubmed/31571834
http://dx.doi.org/10.2147/DDDT.S207561

Ejemplares similares